The latest gastro-intestinal cancer news
Young-onset cancers in Australia rise, and experts don’t know why
Rising numbers of young men and women aged under 50 suffering from gastrointestinal cancers –…
Browsing: GI Cancers
ASCO GI 2022: Ripretinib demonstrates comparable efficacy and fewer side effects compared to sunitinib in patients with GIST previously treated with imatinib
In this, large, phase 3 trial, ripretinib was not found to be better than sunitinib…
Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells
Immunotherapy given before surgery caused liver cancer tumours to die off in one-third of the…
ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to chemotherapy alone
“The current standard of care for inoperable biliary tract cancer is combined chemotherapy. That standard…
ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer compared to sorafenib
“To date, the HIMALAYA study is one of the largest phase III studies conducted with…
Mouse study identifies bacterial protein associated with colorectal cancers
Strains of bacteria that cause common food-poisoning symptoms often contain a toxin that can damage…
New findings may contribute to better diagnosis and treatment of liver cancer
In a new study, researchers at Karolinska Institutet in Sweden have identified the presence of…
Researchers identify new drug combo for liver cancer via CRISPR-Cas9 screen
A research team of LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has…
Study sets framework for precision surveillance of colorectal cancer
A team of Vanderbilt researchers in the USA has revealed some of the mechanisms by…
What is the impact of first-line nivolumab on subsequent therapy choices for metastatic gastric cancer?
Knock-on effects of early immune checkpoint inhibitor use stimulate consideration of alternative approaches for further…